Influence of Gamma-glutamyl carboxylage (GGCX) on warfarin dose
| dc.contributor.author | Zhalbinova, M. | |
| dc.contributor.author | Rakhimova, S. | |
| dc.contributor.author | Bekbosynova, M. | |
| dc.contributor.author | Myrzakhmetova, Sh. | |
| dc.contributor.author | Akilzhanova, A. | |
| dc.date.accessioned | 2016-05-31T03:37:55Z | |
| dc.date.available | 2016-05-31T03:37:55Z | |
| dc.date.issued | 2016-05 | |
| dc.description.abstract | Warfarin is an oral anticoagulant which is popular in cardiology for the prevention and treatment of thromboembolic events in patients with deep vein thrombosis. Patients usually treated according to the clinical data. However, incorrect dose of the treatment can be followed with side effects such as excessive bleeding and thrombosis. To avoid these side effects patients need genetic tests for specific genes which are responsible for the sensitivity of patient to warfarin. GGCX is one of the genes which have a role in dose of the warfarin | ru_RU |
| dc.identifier.citation | M. Zhalbinova, S. Rakhimova, M. Bekbosynova, Sh. Myrzakhmetova, and A. Akilzhanova. 2016. Influence of Gamma-glutamyl carboxylage (GGCX) on warfarin dose. Abstract book. 4 th International Scientific Conference “Regenerative medicine & healthy aging”. National Laboratory Astana, Nazarbayev University. http://nur.nu.edu.kz/handle/123456789/1533 | ru_RU |
| dc.identifier.uri | http://nur.nu.edu.kz/handle/123456789/1533 | |
| dc.language.iso | en | ru_RU |
| dc.publisher | National Laboratory Astana, NAZARBAYEV UNIVERSITY | ru_RU |
| dc.rights | Attribution-NonCommercial-ShareAlike 3.0 United States | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/us/ | * |
| dc.subject | warfarin | ru_RU |
| dc.subject | GGCX | ru_RU |
| dc.subject | anticoagulant | ru_RU |
| dc.title | Influence of Gamma-glutamyl carboxylage (GGCX) on warfarin dose | ru_RU |
| dc.type | Abstract | ru_RU |